ARISTO — Aristo Bio-Tech and Lifescience Balance Sheet

0.000.00%

Last trade - 00:00

Basic MaterialsSpeculativeMicro CapContrarian

Annual balance sheet for Aristo Bio-Tech and Lifescience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	4.16	18.5	6.37	11.2	26.3
Net Total Accounts Receivable
Net Total Receivables	378	498	638	667	639
Total Inventory
Total Other Current Assets
Total Current Assets	625	831	1,050	1,158	1,302
Net Property, Plant And Equipment	145	167	217	240	236
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	770	998	1,273	1,406	1,552
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	510	595	836	956	1,035
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	622	697	937	1,033	1,111
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	148	302	336	373	441
Total Liabilities & Shareholders' Equity	770	998	1,273	1,406	1,552
Total Common Shares Outstanding